* Excellent commercial momentum, fuelled by Rolling Stock and North America * Group book-to-bill ratio(1) of 1.2 * Rolling Stock book-to-bill ratio(1) of 1.4 * All product lines contributing to strong sales growth * Group sales at EUR9,059 million, up 3.2%, of which 7.9% on an organic(1) basis * Strong sales performance in Europe (up 8.5%) supported by both Rolling Stock and Signalling * Steady margin progression * Adjusted EBIT(1) up 13% to EUR580 million compared to H1 2024/25 * Adjusted...